How This CRISPR Biotech Could Make Investors Rich Post author:Sam Post published:December 26, 2017 Post category:BioPharma A look at a biotech company that represents a solid trend in the industry. Source: BioSpace You Might Also Like Teligent Announces FDA Approval Of Erythromycin Topical Gel USP, 2% July 20, 2017 <b>rHEALTH</b> Announces Ongoing Collaboration With Bioverativ March 6, 2017 Bay Area's Rani Therapeutics Lands $53M as Company Moves to Clinical Trials February 7, 2018
